JEREMY BERBEREIA: Open Payments
NPI 1508279381 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 70 payments from 16 companies in 2025. Trend: 2023 $1,500 · 2024 $1,871 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $301 |
| Abbott Laboratories | 21 | $253 |
| Boston Scientific Corporation | 7 | $196 |
| Biosense Webster, Inc. | 1 | $122 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $104 |
| Novo Nordisk Inc | 5 | $76 |
| Shockwave Medical, Inc | 3 | $76 |
| ABIOMED | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Amgen Inc. | 2 | $29 |
Products named: WATCHMAN FLX, QDOT MICRO, LifeVest, WAINUA, FARXIGA, Wegovy, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, GALLANT.
Industry payments across MO — which companies pay providers there.
